(S (NP (NP (NNP Diabetic) (NNP Retinopathy)) (-LRB- -LRB-) (NP (NNP DR)) (-RRB- -RRB-)) (VP (VBZ is) (NP (NP (DT a) (VBG leading) (NN cause)) (PP (IN of) (NP (NP (NN blindness)) (PP (IN in) (NP (VBG working) (NN age) (NNS adults))))))) (. .))
(S (S (NP (NNP DR) (NNS lesions)) (VP (MD can) (VP (VB be) (ADJP (JJ challenging) (S (VP (TO to) (VP (VB identify) (PP (IN in) (NP (NN fundus) (NNS images)))))))))) (, ,) (CC and) (S (NP (JJ automatic) (NNP DR) (NN detection) (NNS systems)) (VP (MD can) (VP (VB offer) (NP (JJ strong) (JJ clinical) (NN value))))) (. .))
(S (PP (IN Of) (NP (NP (DT the) (ADJP (RB publicly) (JJ available)) (VBN labeled) (NNS datasets)) (PP (IN for) (NP (NNP DR))))) (, ,) (NP (NP (DT the) (JJ Indian) (NNP Diabetic) (NML (NNP Retinopathy) (NNP Image)) (NN Dataset)) (-LRB- -LRB-) (NP (NN IDRiD)) (-RRB- -RRB-)) (VP (VBZ presents) (NP (JJ retinal) (NN fundus) (NNS images)) (PP (IN with) (NP (NP (NN pixel) (HYPH -) (NML (NN level) (NNS annotations))) (PP (IN of) (NP (NP (CD four) (JJ distinct) (NNS lesions)) (: :) (NP (NNS microaneurysms)) (, ,) (NP (NNS hemorrhages)) (, ,) (NP (JJ soft) (NNS exudates)) (CC and) (NP (JJ hard) (NNS exudates))))))) (. .))
(S (NP (PRP We)) (VP (VBP utilize) (NP (DT the) (NN HEDNet) (NN edge) (NN detector)) (S (VP (TO to) (VP (VP (VB solve) (NP (DT a) (JJ semantic) (NN segmentation) (NN task)) (PP (IN on) (NP (DT this) (NN dataset)))) (, ,) (CC and) (ADVP (RB then)) (VP (VB propose) (NP (NP (DT an) (NML (NML (NN end)) (HYPH -) (PP (IN to) (HYPH -) (NP (NN end)))) (NN system)) (PP (IN for) (NP (NP (NN pixel) (HYPH -) (NN level) (NN segmentation)) (PP (IN of) (NP (NNP DR) (NNS lesions)))))) (PP (IN by) (S (VP (VBG incorporating) (NP (NN HEDNet)) (PP (IN into) (NP (DT a) (JJ Conditional) (NN Generative) (NML (NNP Adversarial) (NNP Network)) (PRN (-LRB- -LRB-) (NP (NN cGAN)) (-RRB- -RRB-)))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP design) (NP (NP (DT a) (NN loss) (NN function)) (SBAR (WHNP (WDT that)) (S (VP (VBZ adds) (NP (JJ adversarial) (NN loss)) (PP (IN to) (NP (NN segmentation) (NN loss)))))))) (. .))
(S (NP (PRP$ Our) (NNS experiments)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (DT the) (JJ adversarial) (NN loss)))) (VP (VBZ improves) (NP (NP (DT the) (NN lesion) (NN segmentation) (NN performance)) (PP (IN over) (NP (DT the) (NN baseline)))))))) (. .))
